Skip to main content

Predictive factors of recurrence and survival of upper tract urothelial carcinomas

World Journal of Urology volume 29, pages 495–501 (2011)Cite this article

Abstract

Objective

UTUCC is a rare tumor, and most reports on prognostic factors come from small single-center series. The objective of this article was to provide an updated overview of current clinical, pathological and biological prognostic factors of UTUC.

Methods

PubMed was searched for records from 2002 to 2010 using the terms “prognostic factors”, “recurrence”, “survival”, and “upper tract urothelial carcinoma”. Among identified citations, papers were selected based on their clinical relevance.

Results

Classical clinical factors that influence UTUC prognosis include age, presence of symptoms, hydronephrosis, and interval from diagnosis. Many biomarkers have shown promises to better appraise the natural course of UTUC although none is currently used in clinical practice. Stage, grade, lymph node metastases, lymphovascular invasion, tumor necrosis, and tumor architecture are strong pathological parameters. RNU is the standard treatment of localized UTUC. Both laparoscopic and open approaches seem to offer similar cancer control. Lymph node dissection increases staging accuracy and might confer a survival benefit.

Conclusion

RNU is the standard treatment for most patients with UTUC. Recent multicenter studies confirmed the prognostic value of classical prognostic parameters. Better survival prediction might be obtained with prognostic systems including clinical data and new biomarkers.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Abbreviations

CIS:

Carcinoma in situ

CSM:

Cancer-specific mortality

LN:

Lymph node

LVI:

Lymphovascular invasion

RNU:

Radical nephroureterectomy

SEER:

Surveillance epidemiology and end results

TNM:

Tumor, nodes, and metastases

UTUC:

Upper tract urothelial carcinoma

UTUCC:

Upper tract urothelial carcinoma collaboration

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249

    PubMed  Article  Google Scholar 

  2. Oosterlinck W, Solsona E, van der Meijden AP et al (2004) EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46:147–154

    PubMed  Article  CAS  Google Scholar 

  3. Roupret M, Wallerand H, Traxer O et al (2010) Checkup and management of upper urinary tract tumours in 2010: An update from the committee of cancer from the French National Association of Urology. Prog Urol 20:260–271

    PubMed  Article  CAS  Google Scholar 

  4. Zigeuner R, Pummer K (2008) Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur Urol 53:720–731

    PubMed  Article  Google Scholar 

  5. Raman JD, Scherr DS (2007) Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol 4:432–443

    PubMed  Article  Google Scholar 

  6. Cornu JN, Roupret M, Carpentier X et al (2010) Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol 28:151–156

    PubMed  Article  Google Scholar 

  7. Bagley DH, Grasso M 3rd (2010) Ureteroscopic laser treatment of upper urinary tract neoplasms. World J Urol 28:143–149

    PubMed  Article  Google Scholar 

  8. Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 15(115):1224–1233

    Article  Google Scholar 

  9. Shariat S, Godoy G, Lotan Y et al (2010) Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 105:1672–1677

    PubMed  Article  Google Scholar 

  10. Jeldres C, Sun M, Lughezzani G et al (2010) Highly predictive survival nomogram after upper urinary tract urothelial carcinoma. Cancer 116:3774–3784

    PubMed  Article  Google Scholar 

  11. Lughezzani G, Sun M, Perrotte P et al (2010) Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology 75:321–327

    PubMed  Article  Google Scholar 

  12. Shariat SF, Favaretto RL, Gupta A et al (2010) Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. doi:10.1007/s00345-010-0594-7

  13. Patard JJ, Leray E, Cindolo L et al (2004) Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 172:858–862

    PubMed  Article  Google Scholar 

  14. Raman JD, Shariat SF, Karakiewicz PI et al (2010) Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol (in press)

  15. Inman BA, Tran VT, Fradet Y, Lacombe L (2009) Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality. Cancer 1(115):2853–2862

    Article  Google Scholar 

  16. Brien JC, Shariat SF, Herman MP et al (2010) Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 184:69–73

    PubMed  Article  Google Scholar 

  17. Cho KS, Hong SJ, Cho NH, Choi YD (2007) Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma. Urology. 70:662–666

    PubMed  Article  Google Scholar 

  18. Ng CK, Shariat SF, Lucas SM et al (2011) Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma? Urol Oncol 29:27–32

    PubMed  Article  Google Scholar 

  19. Gore J, Lai J, Setodji C, Litwin M, Saigal C (2009) Project UDiA. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 115:988–996

    PubMed  Article  Google Scholar 

  20. Waldert M, Karakiewicz PI, Raman JD et al (2010) A delay in radical nephroureterectomy can lead to upstaging. BJU Int 105:812–817

    PubMed  Article  Google Scholar 

  21. Fromont G, Roupret M, Amira N et al (2005) Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. Eur Urol 48:764–770

    PubMed  Article  CAS  Google Scholar 

  22. Eltz S, Comperat E, Cussenot O, Roupret M (2008) Molecular and histological markers in urothelial carcinomas of the upper urinary tract. BJU Int 102:532–535

    PubMed  Article  CAS  Google Scholar 

  23. Roupret M, Azzouzi AR, Cussenot O (2005) Microsatellite instability and transitional cell carcinoma of the upper urinary tract. BJU Int 96:489–492

    PubMed  Article  CAS  Google Scholar 

  24. Matsui Y, Utsunomiya N, Ichioka K et al (2005) Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 65:279–283

    PubMed  Article  Google Scholar 

  25. Huang WW, Huang HY, Liao AC et al (2009) Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection. Pathol Int 59:642–649

    PubMed  Article  Google Scholar 

  26. Hattori R, Yoshino Y, Komatsu T, Matsukawa Y, Ono Y, Gotoh M (2009) Pure laparoscopic complete excision of distal ureter with a bladder cuff for upper tract urothelial carcinoma. World J Urol 27:253–258

    PubMed  Article  Google Scholar 

  27. Capitanio U, Shariat SF, Isbarn H et al (2009) Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol 56:1–9

    PubMed  Article  Google Scholar 

  28. Favaretto R, Shariat S, Chade D et al (2010) Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol 58(5):645–651

    Google Scholar 

  29. Roupret M, Smyth G, Irani J et al (2009) Oncological risk of laparoscopic surgery in urothelial carcinomas. World J Urol 27:81–88

    PubMed  Article  Google Scholar 

  30. Simone G, Papalia R, Guaglianone S et al (2009) Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 56:520–526

    PubMed  Article  Google Scholar 

  31. Liapis D, de la Taille A, Ploussard G et al (2008) Analysis of complications from 600 retroperitoneoscopic procedures of the upper urinary tract during the last 10 years. World J Urol 26:523–530

    PubMed  Article  Google Scholar 

  32. Hemal AK, Kumar A, Gupta NP, Seth A (2008) Retroperitoneal nephroureterectomy with excision of cuff of the bladder for upper urinary tract transitional cell carcinoma: comparison of laparoscopic and open surgery with long-term follow-up. World J Urol 26:381–386

    PubMed  Article  Google Scholar 

  33. Thalmann GN, Markwalder R, Walter B, Studer UE (2002) Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol 168:1381–1385

    PubMed  Article  Google Scholar 

  34. Nonomura N, Ono Y, Nozawa M et al (2000) Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract. Eur Urol 38:701–704 (discussion 5)

    PubMed  Article  CAS  Google Scholar 

  35. Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H (2006) Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol 176:48–52

    PubMed  Article  Google Scholar 

  36. Novara G, De Marco V, Gottardo F et al (2007) Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 110:1715–1722

    PubMed  Article  Google Scholar 

  37. Raman JD, Ng CK, Scherr DS et al (2010) Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 57:1072–1079

    PubMed  Article  Google Scholar 

  38. Isbarn H, Jeldres C, Shariat SF et al (2009) Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J Urol 182:2177–2181

    PubMed  Article  Google Scholar 

  39. Remzi M, Haitel A, Margulis V et al (2009) Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 103:307–311

    PubMed  Article  Google Scholar 

  40. Margulis V, Youssef RF, Karakiewicz PI et al (2010) Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 184:453–458

    PubMed  Article  Google Scholar 

  41. Langner C, Hutterer G, Chromecki T, Rehak P, Zigeuner R (2006) Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Arch 448:604–611

    PubMed  Article  CAS  Google Scholar 

  42. Li WM, Li CC, Ke HL, Wu WJ, Huang CN, Huang CH (2009) The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. J Urol 182:451–458 (discussion 8)

    PubMed  Article  Google Scholar 

  43. Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ (2010) Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma. Urology 75:328–332

    PubMed  Article  Google Scholar 

  44. Li CC, Chang TH, Wu WJ et al (2008) Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 54:1127–1134

    PubMed  Article  Google Scholar 

  45. Novara G, De Marco V, Gottardo F et al (2007) Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 110:1715–1722

    PubMed  Article  Google Scholar 

  46. Huben RP, Mounzer AM, Murphy GP (1988) Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 62:2016–2020

    PubMed  Article  CAS  Google Scholar 

  47. Roscigno M, Shariat SF, Margulis V et al (2009) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181:2482–2489

    PubMed  Article  Google Scholar 

  48. Capitanio U, Suardi N, Shariat SF et al (2009) Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer. BJU Int 103:1359–1362

    PubMed  Article  Google Scholar 

  49. Roscigno M, Shariat SF, Freschi M et al (2009) Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. Urology 74:1070–1074

    PubMed  Article  Google Scholar 

  50. Roscigno M, Shariat SF, Margulis V et al (2009) The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 56:512–518

    PubMed  Article  Google Scholar 

  51. Bolenz C, Shariat SF, Fernandez MI et al (2009) Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int 103:302–306

    PubMed  Article  Google Scholar 

  52. Hong B, Park S, Hong JH, Kim CS, Ro JY, Ahn H (2005) Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract. Urology 65:692–696

    PubMed  Article  Google Scholar 

  53. Shariat SF, Svatek RS, Tilki D et al (2010) International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105:1402–1412

    PubMed  Article  Google Scholar 

  54. Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K (2007) Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol 178:2291–2296 (discussion 6)

    PubMed  Article  Google Scholar 

  55. Bolenz C, Fernandez MI, Trojan L et al (2009) Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis. BJU Int 103:1040–1046

    PubMed  Article  Google Scholar 

  56. Novara G, Matsumoto K, Kassouf W et al (2010) Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 57:1064–1071

    PubMed  Article  Google Scholar 

  57. Kikuchi E, Margulis V, Karakiewicz PI et al (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 1(27):612–618

    Google Scholar 

  58. Lopez-Beltran A, Bassi P, Pavone-Macaluso M, Montironi R (2004) Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. Eur Urol 45:257–266

    PubMed  Article  Google Scholar 

  59. van der Poel HG, Antonini N, van Tinteren H, Horenblas S (2005) Upper urinary tract cancer: location is correlated with prognosis. Eur Urol 48:438–444

    PubMed  Article  Google Scholar 

  60. Langner C, Hutterer G, Chromecki T, Leibl S, Rehak P, Zigeuner R (2006) Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract. J Urol 176:910–913 (discussion 3–4)

    PubMed  Article  Google Scholar 

  61. Simone G, Papalia R, Loreto A, Leonardo C, Sentinelli S, Gallucci M (2009) Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma. BJU Int 103:1052–1057

    PubMed  Article  Google Scholar 

  62. Zigeuner R, Shariat S, Margulis V et al (2010) Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57:575–581

    PubMed  Article  Google Scholar 

  63. Seitz C, Gupta A, Shariat S et al (2010) Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. J Urol 184:1895–1900

    PubMed  Article  Google Scholar 

  64. Shariat SF, Palapattu GS, Karakiewicz PI et al (2007) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Eur Urol 51:152–160

    PubMed  Article  Google Scholar 

  65. Pieras E, Frontera G, Ruiz X, Vicens A, Ozonas M, Piza P (2010) Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 106:1319–1323

    PubMed  Article  Google Scholar 

  66. Wheat JC, Weizer AZ, Wolf JS Jr et al (2010) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol (in press)

  67. Karam JA, Margulis V, Montorsi F et al (2008) Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy–results from a multicenter study. Eur Urol 54:961–963

    PubMed  Article  Google Scholar 

  68. Otto W, Shariat SF, Fritsche HM, et al (2011) Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World J Urol. doi:10.1007/s00345-011-0645-8

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Affiliations

  1. Department of Urology, CHU Rennes, University of Rennes, Rennes, France

    Grégory Verhoest & Karim Bensalah

  2. Department of Urology, Cornell University Medical College, New York, NY, USA

    Shahrokh F. Shariat, Thomas F. Chromecki & Douglas S. Scherr

  3. Division of Medical Oncology, Cornell University Medical College, New York, NY, USA

    Shahrokh F. Shariat, Thomas F. Chromecki & Douglas S. Scherr

  4. Department of Urology, Penn State College of Medicine, Hershey, PA, USA

    Shahrokh F. Shariat

  5. Department of Urology, Medical University Graz, Graz, Austria

    Thomas F. Chromecki

  6. Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

    Jay D. Raman & Vitaly Margulis

  7. Department of Urology, University of Padua, Padua, Italy

    Giacomo Novara

  8. Department of Urology, Hospital Barmherzige Brüder Vienna, Vienna, Austria

    Christian Seitz

  9. Department of Urology, Hospital Weinviertel-Korneuburg, Korneuburg, Austria

    Mesut Remzi

  10. Department of Urology, La Pitié Salpétrière Hospital, Paris, France

    Morgan Rouprêt

  11. Department of Urology, Rennes University Hospital, Rue Henri Le Guillou, 35033, Rennes Cedex, France

    Karim Bensalah

Authors
  1. Grégory Verhoest
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shahrokh F. Shariat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas F. Chromecki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jay D. Raman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vitaly Margulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giacomo Novara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Christian Seitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mesut Remzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Morgan Rouprêt
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Douglas S. Scherr
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Karim Bensalah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karim Bensalah.

Additional information

G. Verhoest and S. F. Shariat contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Verhoest, G., Shariat, S.F., Chromecki, T.F. et al. Predictive factors of recurrence and survival of upper tract urothelial carcinomas. World J Urol 29, 495–501 (2011). https://doi.org/10.1007/s00345-011-0710-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-011-0710-3

Keywords

  • Transitional carcinoma
  • Upper tract
  • Nephroureterectomy
  • Predictive factors
  • Recurrence
  • Urothelial carcinoma